All blog posts
Total 32 results for
Showing 32 out of 32 results
12 March 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
26 February 2026
Using AI in disclosure
25 February 2026
Trade Secrets – the strategic role of trade secrets in IP protection and how to secure and monitor trade secrets and enforce them across borders
11 February 2026
Supreme Court overrules Aerotel and aligns UK approach to AI and computer-implemented inventions with the EPO
09 February 2026
Preliminary injunctions and "unreasonable delay" at the UPC - Key Takeaways from recent UPC PI decisions
09 February 2026
HSF Kramer contributes to Lexis Nexis Practice Note on the Protection of Geographical Indications
06 February 2026
Selling your AI digital twin - the brave new world of identity-led IP transactions: The Khaby Lame deal analysed
19 January 2026
Where is the UPC after two and a half years - and what to expect in 2026?
Showing 32 out of 32 results
Key contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London